Year : 2018 | Volume
: 1 | Issue : 1 | Page : 1--2
Ushering in a new era: The IJNO
Seth GS Medical College and King Edward VII Memorial Hospital; Department of Neurosurgery, Seth GS Medical College and King Edward VII Memorial Hospital, Mumbai, Maharashtra, India
Prof. Dattatraya Muzumdar
Department of Neurosurgery, Seth G S Medical College and King Edward VII Memorial Hospital, Parel, Mumbai - 400 012, Maharashtra
|How to cite this article:|
Muzumdar D. Ushering in a new era: The IJNO.Int J Neurooncol 2018;1:1-2
|How to cite this URL:|
Muzumdar D. Ushering in a new era: The IJNO. Int J Neurooncol [serial online] 2018 [cited 2022 Jun 25 ];1:1-2
Available from: https://www.Internationaljneurooncology.com/text.asp?2018/1/1/1/245359
It gives me immense pleasure to present the inaugural issue of the Official Journal of The Indian Society of Neuro-Oncology. As you aware, the Indian Society of Neuro-Oncology is a multidisciplinary organization, which aims at providing a platform for effective collaboration between the varied disciplines catering to the field of neuro-oncology. Since its inception in 2009, it has evolved into a robust organization dedicated to advancement of training, treatment protocols, and basic and translational research in neuro-oncology.
The field of neuro-oncology is a relatively new concept in this part of the world. The care for brain and spinal cord tumor patients is given in an individualized manner without any formal collaboration between individual disciplines. There is a silent disconnect between the neurosurgeons, neuroradiologist, neuropathologist, and radiation and medical oncologist. The basic scientist and palliative care is not an integral part of the neuro-oncology program. However, neuro-oncology tumor board meetings, which brainstorm issues related to brain and spinal tumors were the key for establishing a comprehensive neuro-oncology program. They were pivotal and instrumental in providing scaffolding for the neuro-oncology community to form a collaborative network. It created an atmosphere for constructive deliberations and paved the way for continuing medical education programs to understand the biological behavior of brain tumor and its implications in management and prognostication of brain tumors. The goal of the journal remains the publication of this robust work that moves the field forward.
On the background of exponential growth of the society in terms of membership, participation in annual conference, and CME meetings as well as enthusiasm among neuro-oncology fraternity, it was a felt need to provide a platform for clinicians and researchers in neuro-oncology to showcase their lifetime clinical and research work. The International Journal of Neurooncology would solicit articles related to original research, review articles, meta-analysis and collaborative studies, national and international, which would have a positive impact in the management of brain and spinal tumor patients. The goal is to increase our understanding of the biology of nervous system tumors and neurologic complications of brain cancer. This will help to improve the outcomes and quality of life of our patients. Clinical trials with correlative laboratory studies are welcome, even if the results are negative. The progress in the basic mechanisms of neoplastic disease and cancer progression can provide crucial lead to new therapeutic approaches that may benefit subsets of patients with highly aggressive nervous system tumors. The molecular correlates used in diagnostic neuropathology need to translate into clinical studies, which would help evolve targeted therapy for effective treatment of malignant brain tumors.
The Editorial board has eminent clinicians and researchers who are leading academicians in their respective fields. They are an asset to the neuro-oncology community and the journal. We seek their able guidance in continued progress and evolution of the journal. They would be able to help us with timely and top-quality reviews. Our aim would be to ensure that decisions on important work are made quickly on high-priority manuscripts and that these are published as quickly as possible once accepted. We would also consider manuscripts, which have been rejected from higher-impact journals, along with the reviews from those manuscripts. Although the peer-review process for scientific journals may have limitations, it is perhaps still the best mechanism to disseminate high-quality and impactful work to be made accessible to the scientific community, care providers, and patients in a timely manner.
We seek to have a national as well as international readership. Our team is excited to play a leadership role in continued success of International Journal of Neurooncology. We solicit your support from all of you in the neuro-oncology community. We shall always encourage feedback and suggestions to improve our journal and help raise its stature to a high impact score.